Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Scopus Biopharma Inc (SCPS)

Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Scopus Biopharma Inc 420 Lexington Avenue Suite 300 New York NY 10170 USA

scopusbiopharma.com P: 212-479-2513

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Scopus BioPharma Inc. is a biopharmaceutical company. Its lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing additional new chemical entities to treat other serious diseases with significant unmet medical needs, including systemic sclerosis. Scopus BioPharma Inc. is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 17
Enterprise Value, $K -103
Shares Outstanding, K 42,080
Annual Sales, $ 0 K
Annual Net Income, $ -11,610 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,620 K
EBIT, $ -9,350 K
EBITDA, $ -9,350 K
60-Month Beta -0.27
% of Insider Shareholders 5.10%
% of Institutional Shareholders 0.00%
Float, K 20,014
% Float 94.90%
Short Interest 11
Short Float 0.00%
Short Volume Ratio 1.00

Growth:

1-Year Return 33.33%
3-Year Return -99.83%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Year -40.39%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SCPS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.25
Interest Coverage -0.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar